Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Cardiaccs AS
AS
Active
Org 994338668
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2009 · 16 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cardiaccs AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
10M
7M
5M
2M
0M
2020: 7M
7M
2020
2021: 5M (-29% vs 2020)
5M
-29%
2021
2022: 8M (+60% vs 2021)
8M
+60%
2022
2023: 3M (-62% vs 2022)
3M
-62%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
EBITDA
NOK millions
0M
-2M
-4M
-6M
-7M
2020: -1M
-1M
2020
2021: -2M (-100% vs 2020)
-2M
-100%
2021
2022: 0M (+100% vs 2021)
0M
2022
2023: -6M
-6M
2023
2024: -4M (+33% vs 2023)
-4M
+33%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
355
2 669
7 883
5 147
7 454
Staff expenses
−1 960
−4 306
−4 979
−4 342
−3 383
EBITDA
−4 211
−5 942
−42
−1 853
−825
Depreciation & amort.
−431
−1 967
−2 269
−785
−111
EBIT
−4 643
−7 909
−2 311
−2 638
−936
Net financials
135
861
−53
−332
−276
Profit before tax
−4 508
−7 047
−2 365
−2 970
−1 212
Tax
−0
−0
−0
−0
−0
Net profit
−4 508
−7 047
−2 365
−2 970
−1 212
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
2 612
8 872
18 275
21 885
12 620
Equity
1 473
5 981
11 799
11 617
7 157
Long-term debt
0
0
0
0
0
Short-term debt
1 139
2 891
6 475
9 831
5 463
Total debt
1 139
2 891
6 475
9 831
5 463
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
56,4 %
This company
38,2 %
Market median
This company
Market median
48% above market
2020
2024
Return on equity
−306,1 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,14×
This company
1,12×
Market median
This company
Market median
88% below market
2020
2024
Debt / equity
0,77×
This company
0,62×
Market median
This company
Market median
24% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Cardiaccs AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
